Type A acute aortic dissection complicated by lower limb ischemia

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Andrea Daprati ◽  
Andrea Garatti ◽  
Alberto Canziani ◽  
Alessandro Parolari
Circulation ◽  
2015 ◽  
Vol 132 (suppl_3) ◽  
Author(s):  
Susan Alaei ◽  
Thoralf M Sundt ◽  
Udo Sechtem ◽  
Truls Myrmel ◽  
Marco Di Eusanio ◽  
...  

Background: This study assessed the incidence of lower limb ischemia as well as trends in management and outcomes while examining acute aortic dissection patients over a period of 15 years. Additionally, differences in clinical presentation, interventions performed, and mortality between patients with and without lower limb ischemia were investigated. Methods: Lower limb ischemia (LLI) was evaluated among 3812 patients enrolled in the International Registry of Acute Aortic Dissection over a 15-year period that was separated into three 5-year intervals: 1996-2001, 2002-2007, and 2008-2012. The cohort was then divided by dissection type and presence or absence of LLI. Results: Type A patients presenting with limb ischemia (N=280, 11.4%) were much more likely to have atherosclerosis (p=0.021) and to present with back, abdominal and leg pain versus chest pain (p<0.001 unless noted). Other symptoms of malperfusion, including ischemic spinal cord damage (p<0.001) and coma/altered consciousness (p=0.006) were more common in patients presenting with LLI. Surgery was less commonly performed in Type A LLI patients (79.3% vs 86.1%, p=0.002), a difference that did not change over time (p=0.453, trend p=0.479). Additionally, overall mortality was higher in LLI patients (37.5% vs 22.9%, p<0.001) and did not show improvement among the LLI cohort over time. Type B patients with LLI (N=102, 7.5%) were more likely to be current smokers (p=0.028), to present febrile (p=0.022), and to have leg pain (p<0.001). As with Type A, ischemic spinal cord damage was more common in the LLI cohort (p<0.001). Patients with LLI were much more likely to be managed with endovascular therapy (19.6% vs 50.0%, p<0.001) than with medication alone (66.5% vs 29.4%, p<0.001), with endovascular repair increasing in LLI patients over time (p=0.008, trend p=0.002). Again, overall mortality was higher in the LLI cohort (24.5% vs 9.7%, p<0.001) and did not change over time. Conclusions: Although Type B patients with LLI received more endovascular procedures in later years, overall mortality did not improve. Increased complications and higher mortality in the LLI cohort suggests a need for better monitoring and increased implementation of interventions in this population.


2021 ◽  
Vol 50 (6) ◽  
pp. 405-409
Author(s):  
Kiyotaka Suzuki ◽  
Keiji Uchida ◽  
Tomoyuki Minami ◽  
Tomoki Cho ◽  
Yusuke Matsuki ◽  
...  

Angiology ◽  
1993 ◽  
Vol 44 (9) ◽  
pp. 755-759 ◽  
Author(s):  
Noriyuki Kato ◽  
Hajime Sakuma ◽  
Kan Takeda ◽  
Tadanori Hirano ◽  
Tsuyoshi Nakagawa

2019 ◽  
Vol 46 (2) ◽  
pp. 130-132
Author(s):  
Kazuhiro Kurisu ◽  
Satoshi Kimura ◽  
Hiroshi Mitsuo ◽  
Yasutaka Ueno

Acute aortic dissection can be complicated by malperfusion syndromes, including ischemia of the lower limbs. In some cases, delayed correction of leg ischemia leads to reperfusion injury, potentially resulting in renal failure. We describe the case of a 64-year-old woman who presented with acute aortic dissection manifesting itself as lower-limb ischemia. During and after aortic surgery with cardiopulmonary bypass, the patient developed myonephropathic metabolic syndrome. Hyperkalemia was corrected and acute kidney injury was prevented by infusing large volumes of intravenous fluids and administering human atrial natriuretic peptide. Peripheral bypass surgery was unnecessary. This case suggests that restoring blood flow to an ischemic leg by means of adjunctive perfusion during aortic repair with cardiopulmonary bypass is a viable way to overcome the biochemical instability associated with prolonged ischemia, especially hyperkalemia in the early phase of reperfusion.


2016 ◽  
Vol 31 ◽  
pp. 208.e9-208.e14 ◽  
Author(s):  
Akihiko Ikeda ◽  
Yohei Kudo ◽  
Taisuke Konishi ◽  
Kanji Matsuzaki ◽  
Tomoaki Jikuya

Vascular ◽  
2013 ◽  
Vol 22 (2) ◽  
pp. 121-126 ◽  
Author(s):  
Lorraine Corfield ◽  
David J McCormack ◽  
Rachel Bell ◽  
Peter Taylor ◽  
John Reidy

Acute limb ischemia due to type B aortic dissection is rare and continues to be a management challenge. A case series is presented here with the aim of assessing the outcomes of treatment with a femorofemoral crossover graft with or without thoracic stent graft insertion. This is a combined retrospective and prospective review of nine cases of acute lower limb ischemia secondary to acute type B aortic dissection. The presenting features, radiological findings, treatment and outcomes were reviewed. Five patients had a femorofemoral crossover graft (FFXO) alone, two an FFXO with a thoracic stent graft and the eighth a thoracic and iliac stent. The other case was initially treated conservatively but subsequently required an FFXO. The mean follow-up was 16 (3–51) months. A further two thoracic stents were placed during the follow-up period. Thus five out of nine patients (56%) required aortic stenting. This series suggests that an FFXO is a reliable treatment for acute limb ischemia due to type B aortic dissection. However, these patients are often complex with ischemia in other vascular beds and are at risk of subsequent aneurysmal dilation.


Sign in / Sign up

Export Citation Format

Share Document